All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AQUESTIVE THERAPEUTICS, INC.: Last Reported 3/31/2020

Business Address

30 TECHNOLOGY DRIVE

WARREN, NJ US 07059

Mailing Address

30 TECHNOLOGY DRIVE

WARREN, NJ US 07059
Phone Number: 908-941-1900 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 7/31/2018 6/30/2018 4/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash and Cash Equivalents $35,521,000.00 $49,326,000.00 $20,914,000.00 $22,165,000.00 $39,934,000.00 $60,599,000.00 $63,982,000.00 -- $10,638,000.00 -- -- $17,379,000.00 $25,443,000.00 $10,289,000.00 -- $9,209,000.00
Accounts Receivable Net Current -- -- -- -- -- -- $7,450,000.00 -- $6,629,000.00 -- -- $6,179,000.00 -- -- -- --
Inventory $3,087,000.00 $2,859,000.00 $4,124,000.00 $4,647,000.00 $5,137,000.00 $5,441,000.00 $4,483,000.00 -- $4,348,000.00 -- -- $4,014,000.00 -- -- -- --
Prepaid Expenses and Other Current Assets $2,944,000.00 $2,999,000.00 $2,706,000.00 $2,102,000.00 $3,398,000.00 $1,680,000.00 $1,444,000.00 -- $5,034,000.00 -- -- $591,000.00 -- -- -- --
Total Current Assets $51,088,000.00 $68,314,000.00 $38,060,000.00 $39,064,000.00 $55,958,000.00 $74,201,000.00 $77,359,000.00 -- $26,649,000.00 -- -- $28,163,000.00 -- -- -- --
Property Plant and Equipement $9,059,000.00 $9,726,000.00 $10,351,000.00 $10,933,000.00 $11,594,000.00 $12,207,000.00 $12,211,000.00 -- $12,766,000.00 -- -- $13,460,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $288,000.00 $286,000.00 $242,000.00 $233,000.00 $236,000.00 $239,000.00 $224,000.00 -- $197,000.00 -- -- $1,239,000.00 -- -- -- --
Total Assets $64,487,000.00 $78,479,000.00 $48,818,000.00 $50,408,000.00 $67,979,000.00 $86,851,000.00 $90,010,000.00 -- $39,841,000.00 -- -- $43,116,000.00 -- -- -- --
Accounts Payable $10,283,000.00 $12,274,000.00 $14,202,000.00 $20,034,000.00 $19,145,000.00 $20,436,000.00 $12,337,000.00 -- $16,522,000.00 -- -- $9,601,000.00 -- -- -- --
Accrued Liabilities -- $5,475,000.00 -- -- -- $7,195,000.00 -- -- -- -- -- $4,402,000.00 -- -- -- --
Total Current Liabilities $85,316,000.00 $84,601,000.00 $83,277,000.00 $75,065,000.00 $74,035,000.00 $76,771,000.00 $66,566,000.00 -- $78,789,000.00 -- -- $69,611,000.00 -- -- -- --
Long Term Debt $70,000,000.00 $70,000,000.00 $70,000,000.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-147,004,000.00 $-130,474,000.00 $-117,838,000.00 $-99,426,000.00 $-78,954,000.00 $-61,376,000.00 $-47,432,000.00 -- $-32,394,000.00 -- -- $-120,093,000.00 -- -- -- --
Total Stockholders' Equity $-20,829,000.00 $-6,122,000.00 $-34,459,000.00 $-24,657,000.00 $-6,056,000.00 $10,080,000.00 $23,444,000.00 -- $-38,948,000.00 -- $-22,396,000.00 $-68,596,000.00 -- -- -- $-57,197,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $64,487,000.00 $78,479,000.00 $48,818,000.00 $50,408,000.00 $67,979,000.00 $86,851,000.00 $90,010,000.00 -- $39,841,000.00 -- -- $43,116,000.00 -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 7/31/2018 6/30/2018 4/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues -- -- -- -- -- $16,824,000.00 $13,267,000.00 -- $13,928,000.00 -- $23,411,000.00 $12,194,000.00 $54,723,000.00 $11,142,000.00 $16,436,000.00 --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $4,354,000.00 $20,574,000.00 $17,517,000.00 $12,454,000.00 $4,303,000.00 $23,112,000.00 $4,534,000.00 -- $12,895,000.00 -- $4,901,000.00 $22,133,000.00 $15,862,000.00 $4,837,000.00 -- --
Selling, General, and Administrative $14,613,000.00 $64,342,000.00 $47,868,000.00 $34,154,000.00 $17,908,000.00 $72,264,000.00 $53,561,000.00 -- $41,216,000.00 -- $7,569,000.00 $25,078,000.00 $6,161,000.00 $11,352,000.00 -- --
Total Operating Expenses $22,626,000.00 $26,323,000.00 $78,954,000.00 $29,817,000.00 $25,717,000.00 $29,173,000.00 $22,471,000.00 -- $64,720,000.00 -- $18,106,000.00 $19,450,000.00 $16,725,000.00 $15,201,000.00 $15,655,000.00 --
Loss from Operations $-13,861,000.00 $-52,668,000.00 $-42,764,000.00 $-31,762,000.00 $-13,074,000.00 $-48,934,000.00 $-36,585,000.00 -- $-32,686,000.00 -- $5,305,000.00 $-113,000.00 $10,421,000.00 $-3,278,000.00 -- --
Loss Before Income Taxes $-16,530,000.00 $-66,246,000.00 $-18,412,000.00 $-35,198,000.00 $-14,726,000.00 $-61,376,000.00 $-47,432,000.00 -- $-36,493,000.00 -- $4,099,000.00 $-8,943,000.00 $1,097,000.00 $-5,897,000.00 -- --
Earnings Per Share Basic -- -- $-0.74 $-0.82 -- -- $-0.64 -- $-1.90 -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- 24,992,229 24,972,280 -- -- 23,646,192 -- 17,144,492 -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 350,000,000 350,000,000 25,000 -- -- -- -- --
Common Stock Shares Outstanding 33,582,696 33,562,885 25,042,964 25,022,660 24,975,139 24,957,309 24,942,185 -- -- -- -- -- -- -- -- --
Copyright 2020 PursePoor.com